Immuno-oncology Targeting tumor microenvironment with AMUN-003 inhibits tumor growth and metastasis in vivo Dec. 22, 2022 An Amunbio Inc.-led research team presented preclinical data on immune checkpoint inhibitor (ICI) therapy combined with AMUN-003.Read More
